US-based medical diagnostics company T2 Biosystems has closed a $23m series D round of financing led by US-based investment firm Aisling Capital.

Also participating in the consortium was Physic Ventures, a corporate venturing fund backed by, among others, consumer goods conglomerate Unilever, food and beverages multinational Pepsi and health insurance company Humana.

Physic had previously led T2’s series C round, which raised $15m in May last year. Existing investors also participating in the series D round include the US-based venture…